Ignite Creation Date:
2025-12-24 @ 10:02 PM
Ignite Modification Date:
2025-12-28 @ 9:02 AM
Study NCT ID:
NCT05835635
Status:
NOT_YET_RECRUITING
Last Update Posted:
2024-11-07
First Post:
2023-03-24
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Switch From Oral Therapy to Long-acting Injectable Cabotegravir + Rilpivirine
Sponsor:
Pontificia Universidad Catolica de Chile
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2025-05-01
Start Date Type:
ESTIMATED
Primary Completion Date:
2025-12-01
Primary Completion Date Type:
ESTIMATED
Completion Date:
2026-05-01
Completion Date Type:
ESTIMATED
First Submit Date:
2023-03-24
First Submit QC Date:
None
Study First Post Date:
2023-04-28
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-11-05
Last Update Post Date:
2024-11-07
Last Update Post Date Type:
ACTUAL